Our Fall Program included topics in the following areas. Investing: Health Angel Investing is unique with the opportunity for financial returns and societal impact. Maren Nelson talked about being an angel investor and what key things she looks for in an investor pitch. Ky Calder moderated a great panel discussion with Caitlin Cameron, Susan Preston and Christiana DelloRusso, PhD to share thoughts on being an angel investor. David Giarracco helped us understand the different models for determining Health Company Valuations. Business Models can have a big influence on outcomes shared by Harold Wodlinger. Payment and Value-Based Decision Making: Julie Panek-Anderson spoke about Who Influences the Health System; Chris Saxman talked about who actually pays for health (or really an illness system). Craig Solid talked about how to look at Value Based Decision Making and ROI. Development Process: Laura Jantos stressed the importance of Patient Engagement. Caitlin Morse highlighted aligning on the risk, activities, cost and timeline or a solid foundation in the investor/founder partnership. Scott Thielman spoke about how Investors should evaluate claims of founders for product development status. Jane Lee Choe explained the digital health stack. Regulatory and Intellectual Property: Michelle Lott reinforced that while the FDA is a big deal, it is also part of a strategic advantage, particularly evaluating the different potential pathways and the costs and timeframes for each. Ryan Buckmaster provided methods to protect your intellectual property. Curated Resources: NIH Seed Lead Chris Sasiela and Investor in Residence Stephen Flaim discussed the Seed Program which evaluates good ideas, supports founders in commercializing the ideas, and then showcases this amazing curated company pool to investors. These sessions are viewable on YouTubeApisHealthAngels Optional Workshops Provide Context to Health Industry Challenges